Top Losers

Synchronoss Technologies, Inc. (NASDAQ: SNCR) shares dropped 38.5 percent to $10.30 after Siris Capital disclosed that it is no longer interested in an all cash takeover of the company. Aldeyra Therapeutics Inc (NASDAQ: ALDX) shares dipped 19 percent to $7.37. Aldeyra Therapeutics reported...

LM Funding America, Inc. (NASDAQ: LMFA) shares tumbled 12.8 percent to $2.84. Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares dropped 12.3 percent to $3.22 after climbing 39.54 percent on Friday. XCel Brands Inc (NASDAQ: XELB) shares dipped 11.8 percent to $3.75. NXT-ID Inc (...

T2 Biosystems Inc (NASDAQ: TTOO) shares tumbled 22.1 percent to $4.74. T2 Biosystems priced its 4.375 million share offering at $4 per share. Ominto Inc (NASDAQ: OMNT) shares dropped 19.2 percent to $2.77. LM Funding America, Inc. (NASDAQ: LMFA) shares fell 13.3 percent to $ 2.57....

Summit Therapeutics PLC (ADR) (NASDAQ: SMMT) shares dipped 18.7 percent to $12.40. Summit Therapeutics priced public offering of 1.459 million ADS's at $12.00 per ADS. Workhorse Group Inc (NASDAQ: WKHS) shares dropped 16 percent to $2.95. Workhorse priced its 3.75 million share common...

Applied Genetic Technologies Corp (NASDAQ: AGTC) shares dipped 16.7 percent to $4.12 after the company reported weaker-than-expected Q4 results. Veritone Inc (NASDAQ: VERI) shares declined 10.9 percent to $25.58. Pulse Biosciences Inc (NASDAQ: PLSE) shares fell 9.4 percent to $12.49....

Opiant Pharmaceuticals Inc (NASDAQ: OPNT) shares tumbled 23.4 percent to $37.90. Advaxis, Inc. (NASDAQ: ADXS) shares fell 18.4 percent to $5.57. Advaxis reported a Q3 loss of $32.6 million. Health Insurance Innovations Inc (NASDAQ: HIIQ) shares declined 18.1 percent to $19.13 after...

Health Insurance Innovations Inc (NASDAQ: HIIQ) shares tumbled 24.1 percent to $22.70. Pulse Biosciences Inc (NASDAQ: PLSE) shares dipped 22.1 percent to $15.25 after the company reported the withdrawal and planned resubmission of 510(k) application for PulseTx system. Achillion...

Tintri Inc (NASDAQ: TNTR) shares dipped 26.5 percent to $4.91 after the company reported mixed quarterly results. Bank of America downgraded Tintri from Buy to Neutral. Science Applications International Corp (NYSE: SAIC) shares fell 17.4 percent to $61.75 as the company reported weaker-than...

NCI Building Systems Inc (NYSE: NCS) shares declined 20.1 percent to $13.43 after the company reported weaker-than-expected quarterly results. Airgain Inc (NASDAQ: AIRG) shares dropped 15.1 percent to $9.15 after the company issued sales growth forecast. Airgain expects FY17 sales growth of...

Trivago NV - ADR (NASDAQ: TRVG) shares dipped 24.8 percent to $11.23 after the company lowered its guidance. At Home Group Inc (NYSE: HOME) dropped 11.4 percent to $22.70. At Home Group reported Q2 adjusted earnings of $0.18 per share on revenue of $232.1 million. Pulmatrix Inc (NASDAQ:...

Cellectis SA (ADR) (NASDAQ: CLLS) shares dipped 21.4 percent to $25.30 after announcing FDA clinical hold of UCART123 studies. Heritage Insurance Holdings Inc (NYSE: HRTG) shares tumbled 15.1 percent to $9.56. Universal Insurance Holdings, Inc. (NYSE: UVE) shares fell 13.7 percent to $18...

Ambarella Inc (NASDAQ: AMBA) dropped 21.6 percent to $42.66. Ambarella reported better-than-expected results for its second quarter on Thursday. Craig-Hallum downgraded Ambarella from Buy to Hold. Tech Data Corp (NASDAQ: TECD) shares tumbled 18.6 percent to $89.80. Tech Data posted...

Steadymed Ltd (NASDAQ: STDY) shares tumbled 38.2 percent to $3.65 after the company disclosed that it has received a Refusal To File letter from the FDA related to Trevyent NDA. Magal Security Systems Ltd. (USA) (NASDAQ: MAGS) dropped 13.9 percent to $4.16. Magal Security reported a Q2 loss...

Otonomy Inc (NASDAQ: OTIC) shares dipped 81.1 percent to $3.92 after the company issued results from its AVERTS-1 Phase 3 trial for OTIVIDEX in patients with Meniere's disease. The company disclosed that the trial missed primary endpoint and all key vertigo secondary endpoints. Otonomy...

Acorda Therapeutics Inc (NASDAQ: ACOR) shares dipped 27 percent to $18.77 after the company reported that it has received a Refusal to File letter from the FDA for INBRIJA regarding its previously filed NDA. Finish Line Inc (NASDAQ: FINL) shares tumbled 19.6 percent to $8.38 after the...